Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis.
- 1 January 1986
- journal article
- research article
- Published by Pharmaceutical Society of Japan in Journal of Pharmacobio-Dynamics
- Vol. 9 (5), 437-441
- https://doi.org/10.1248/bpb1978.9.437
Abstract
The effect of oral administration of activated charcoal on the clearance of theophylline and phenobarbital following their intravenous administration was studied in rats. Oral administration of multiple doses of activated charcoal significantly decreased the serum half-life and AUC (area under the curve) and increased the total body clearance of both theophylline and phenobarbital as compared with their respective controls. The volume of distribution was not significantly different between treatments. A single dose of activated charcoal showed only a slight enhancement of clearance of theophylline. Accelerated clearance of both drugs by oral activated charcoal was rationalized in the terms of adsorption of exsorbed drugs and inhibition of their reabsorption by activated charcoal in the gastrointestinal tract.This publication has 7 references indexed in Scilit:
- Acceleration of digoxin clearance by activated charcoalClinical Pharmacology & Therapeutics, 1985
- Transport of theophylline from blood to the intestinal lumen following i.v. administration to rats.Journal of Pharmacobio-Dynamics, 1985
- Preparation and drug adsorption characteristics of activated carbon beads suitable for oral administration.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Enhancement of theophylline clearance by oral activated charcoalClinical Pharmacology & Therapeutics, 1983
- INCREASED SERUM THEOPHYLLINE CLEARANCE WITH ORALLY-ADMINISTERED ACTIVATED-CHARCOAL1983
- Acceleration of the Body Clearance of Phenobarbital by Oral Activated CharcoalNew England Journal of Medicine, 1982
- Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in manEuropean Journal of Clinical Pharmacology, 1980